Who are Probiotic (Lactobacillus reuteri Prodentis's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Synbiotic 2000, Probiotics(VSL#3), Saccharomyces boulardi (Sb), Lactobacillus Fermentum, Probiotic : Saccharomyces boulardii, Bio-three.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/probiotic-lactobacillus-reuteri-prodentis.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Probiotic (Lactobacillus reuteri Prodentis — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Probiotic (Lactobacillus reuteri Prodentis (Probiotic (Lactobacillus reuteri Prodentis) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Probiotic. Area: Dentistry / Oral Health.

marketed Probiotic Dentistry / Oral Health Biologic Live · refreshed every 30 min

Target snapshot

Probiotic (Lactobacillus reuteri Prodentis (Probiotic (Lactobacillus reuteri Prodentis) — Universidad de Colima. Lactobacillus reuteri Prodentis is a probiotic strain that colonizes the oral cavity and produces antimicrobial compounds to inhibit pathogenic bacteria and reduce oral inflammation.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class
Probiotic (Lactobacillus reuteri Prodentis TARGET	Probiotic (Lactobacillus reuteri Prodentis	Universidad de Colima	marketed	Probiotic
Synbiotic 2000	Synbiotic 2000	Beth Israel Medical Center	marketed	Synbiotic (prebiotic + probiotic combination)
Probiotics(VSL#3)	Probiotics(VSL#3)	Govind Ballabh Pant Hospital	marketed	Probiotic
Saccharomyces boulardi (Sb)	Saccharomyces boulardi (Sb)	Fundación Hospital de Pediatría Prof. Dr. Juan P. Garrahan	marketed	Probiotic
Lactobacillus Fermentum	Lactobacillus Fermentum	HEM Pharma Inc.	marketed	Live biotherapeutic / Probiotic
Probiotic : Saccharomyces boulardii	Probiotic : Saccharomyces boulardii	Biocodex	marketed	Probiotic
Bio-three	Bio-three	Kaohsiung Veterans General Hospital.	marketed	Probiotic

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Probiotic class)

BioBalance Corporation · 1 drug in this class
Biocodex · 1 drug in this class
CD Pharma India Pvt. Ltd. · 1 drug in this class
CHU de Quebec-Universite Laval · 1 drug in this class
Chuncheon Sacred Heart Hospital · 1 drug in this class
Dow University of Health Sciences · 1 drug in this class
Federico II University · 1 drug in this class
Fundación Hospital de Pediatría Prof. Dr. Juan P. Garrahan · 1 drug in this class
GWT-TUD GmbH · 1 drug in this class
Aga Khan University · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Probiotic (Lactobacillus reuteri Prodentis — Competitive Intelligence Brief. https://druglandscape.com/ci/probiotic-lactobacillus-reuteri-prodentis. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab